Women's Health
Study data from Massachusetts General Hospital update knowledge of women's health
Published in Women's Health Law Weekly, January 25th, 2009
"This study sought to compare the efficacy and safety of different TRALI risk-reduction strategies at a hospital-based donor center. Samples from 1053 donors who answered questions regarding pregnancy and transfusion history were tested for HLA Class I and II antibodies using a flow cytometry-based screening assay. Donor history was compared with the presence of HLA alloantibodies. These data were used to model several TRALI risk-reduction...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- America's Health Insurance Plans
Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds - Depression Genetics
Data on depression genetics reported by researchers at University of Cincinnati - HiFi DNA Tech
HiFi DNA Tech Tells FDA to Reduce Unnecessary Biopsies on Women; Rescind Approval of Expanded Use of Human Papillomavirus HPV Test Results for Sending Patients to Cancer Workup - Littler Mendelson
Littler Mendelson Welcomes Five New Attorneys to Its San Francisco Office - Obstetrics and Gynecology
Findings from S.L. Clark and co-researchers advance knowledge in obstetrics and gynecology - ReportLinker
Focus on the World Malternatives Market - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
